About
O11 Biomedical GmbH is a spin-off from the Institute for Applied Medical Engineering (BioTex) at RWTH Aachen University and Aachen University Hospital. Its multidisciplinary team of biologists, physicians and engineers is developing a treatment for hypercapnia.
Explore O11 Biomedical GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.